myasthenia gravis Flashcards

1
Q

mg definition

A

a chronic auto-immunye neuromuscular disease causing weakness in the voluntary (skeletal) muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mg caused by a reduced availability of ? at the NMJ

A

acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which dysarthria would you expect with mg

A

flaccid only (failed muscle contractions, never spastic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mg hallmark feature

A
  • skeletal (voluntary) muscle weakness following periods of activity
  • weakness rapidly improves after a period of rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

chronic or gradual onset in mg?

A

both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does the neuromuscular junction work

A
  • axons release neurotransmitter (acetylcholine)
  • neurotransmitter travels across the synapse and attaches to receptors on the post-synaptic membrane
  • receptors are stimulated which causes muscle contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mg pathophysiology

A

body makes antibodies to cockblock the acetylcholine from the receptors :(

  • the immune system produces antibodies that interfere with the NMJ
  • antibodies block, alter, or destroy receptors for acetylcholine at the NMJ
  • prevents muscular contraction from occurring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 prevalence peak decades in mg

A
  • women: 20/30 years
  • men: 70/80 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

gender ratio in mg

A

3:1, f:m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

typical clinical features of mg

A
  • fatigueable ptosis
  • extraocular muscle weakness: diplopia, limitation of eye movements
  • facial weakness
  • weakness of eye closure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ptosis

A

eyelid drooping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the first symptom in 2/3 of mg patients

A

ptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diplopia

A

double vision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

does mg have fasciculations?

A

no, only mnd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mg ocular muscle weakness features

A

fluctuating ptosis, diplopia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mg bulbar muscle weakness features

A
  • dysarthria
  • painless dysphagia
  • dysphonia
  • masticatory weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

mg facial muscle weakness features

A
  • facial weakness
  • inability to close eye firmly
  • drooling of saliva
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

mg axial muscle weakness features

A

flexion or extension of the neck

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

mg limb muscle weakness features

A

weakness involving the arms more than legs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mg respiratory muscle weakness features

A
  • labor breathing
  • orthopnea
  • dyspnea
  • respiratory failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

orthopnea

A

shortness of breath that occurs while lying flat and is relieved by sitting or standing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

dyspnea

A

feeling short of breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

initial bulbar symptom in ?%

A

15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

bulbar signs in mg

A
  • nasal regurgitation
  • hypernasality
  • difficulty masticating solids
  • weak breathy voice quality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

external contributing factors (that can trigger mg symptoms)

A
  • emotional upset
  • hypo-/hyperthyroidism
  • menstrual cycle
  • systemic illness
  • pregnancy
  • increased body temperature (hot baths, fireplace)
  • meds affecting neuromuscular transmission
26
Q

mg rating scale

A
  • Osserman Classification System
27
Q

Osserman Classification System

A
  • Class 1 (any eye muscle weakness, possible ptosis, all other strength is normal)
    to
  • Class 5 (intubation needed to maintain airway)
28
Q

6 subtypes of mg

A
  • ocular
  • early onset
  • late onset
  • thymoma MG
  • seronegative MG x 2
29
Q

role of the thymus gland in risk factors for mg

A
  • 10-20% of people with mg have a thymoma
  • 20-40% of people with a thymoma will develop mg
30
Q

full clinical evaluation

A
  • elicit fatigue
  • repeatedly blink (ptosis)
  • upward gaze (double vision)
  • count 1-100 (dysarthria)
  • abduct arm (unilateral weakness)
  • forced vital capacity
  • hx thymoma
31
Q

mg diagnostic tests

A
  • tensilon (edrophonium) test
  • ice-pack test
  • electrophysiological tests (EMG, nerve conduction)
  • auto-antibody test (blood test)
32
Q

tensilon (edrophonium) test

A
  • prolongs the duration of action of acetylcholine
  • increases the amplitude and duration of the contractions
33
Q

edrophonium chloride function

A

short-acting acetylcholinesterase inhibitor

34
Q

tensilon (edrophonium) test sensitivity

35
Q

the tensilon (edrophonium) test is most reliable in people with ?

A

ptosis, nasal speech, or strabismus

36
Q

important requirement before administering the tensilon (edrophonium) test

A

need to fatigue before administering it to see changes

37
Q

MG prognosis

A
  • relatively normal, not degenerative
  • may go into remission temporarily and muscle weakness can disappear (discontinue meds)
38
Q

MG management

A
  • cholinesterase inhibitors
  • corticosteroids
  • plasma exchange
  • immuno-suppression
  • IVIG
  • thymectomy
39
Q

(MG management) cholinesterase inhibitors

A
  • mimic neurotransmitters and prevent the breakdown of neurotransmitters
  • manage fatigue
40
Q

(MG management) corticosteroids

A
  • complete relief of symptoms in most patients
  • managing acute relapses
  • reduce inflammation in the CNS
41
Q

(MG management) plasma exchange

A
  • 2nd line of therapy (after corticosteroids)
  • blood filter to take out antibodies
  • often 4-5 treatments over 2 weeks in hospital
42
Q

(MG management) immuno-suppression

A
  • stop the immune system from cockblocking the neurotransmitters
  • prednisone
43
Q

(MG management) IVIG

A
  • intraveneous immunoglobulin
  • injected with normal antibodies to change immune system responses
44
Q

(MG management) thymectomy

A

remove enlarged or tumorous thymus

45
Q

2 potential MG crises

A
  • myasthenic crisis
  • cholinergic crisis
46
Q

myasthenic crisis

A
  • severe weakness from MG
  • need intubation for ventilatory support or airway protection
47
Q

intubation for a myasthenic crisis is indicated if ?

A
  • evidence of respiratory muscle fatigue
  • increasing tachypnea
  • declining tidal volumes, hypoxemia, hypercapnea, and difficulty handling secretions
48
Q

favored treatment for myasthenic crisis

A

plasma exchange

49
Q

cholinergic crisis

A
  • overdose of cholinesterase inhibitors
  • sweating, constricted pupils, excessive salivation, muscle fasciculations
50
Q

thymectomy goal

A

stable, long-lasting remissions

51
Q

MG SLT-related assessments

A
  • MG-ADL
  • MG-QOL15
52
Q

SLT assessment in MG

A
  • observe muscle fatigue at rest and during OMA
  • check low tone/flaccidity in OMA
  • evaluate over time
  • stress/fatigue tests (count 1-100, include solids in swallow eval)
53
Q

MG dysarthria

A
  • hypernasality
  • weak, breathy voice
  • low volume
  • misarticulation
  • fatigability
54
Q

dysarthria management

A
  • observe the effects of medical intervention
  • educate causes and factors affecting speech
  • energy conservation (rest before conversation, short sentences, take breaks, calls early in day, non-verbal options, quiet environment)
55
Q

NB for dysarthria management

A
  • muscle strengthening exercises and speech drilling are contra-indicated
  • can’t reverse neurotransmitter blocking
  • will only worsen the dysarthria
56
Q

possible prostheses

A
  • ptosis props
  • palatal lift prosthesis
57
Q

prosis props

A
  • hold eyelids up
  • useful for reading books and watching movies
58
Q

palatal lift prosthesis

A
  • help hold up soft palate
  • good for correcting hypernasality (not misarticulation)
  • removed when eating and drinking
59
Q

dysphagia in MG

A
  • difficulty masticating solid foods (fatigue)
  • nasal regurgitation of fluids
  • weak tongue movements
  • reduced hyolaryngeal excursion
  • poor airway protection
  • impaired UES tone
  • weak cough
60
Q

dysphagia management in MG

A
  • observe effects of medicine
  • education
  • compensatory (small meals, small bolus, avoid chewy solids, multiple swallows)
61
Q

NB for dysphagia management

A

direct rehab contra-indicated